Home > Boards > US OTC > Medical - Drugs >

Elite Pharmaceuticals (ELTP)

Add ELTP Price Alert      Hide Sticky   Hide Intro
Moderator: dr_lowenstein, DR Ryan, NASDAQ2020, IB_, namtae, Chasing
Search This Board: 
Last Post: 10/15/2019 2:39:57 PM - Followers: 876 - Board type: Free - Posts Today: 8

Elite Pharmaceuticals, Inc. (ELTP)


\Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company developing a pipeline of proprietary pharmacological abuse-deterrent opioid products and niche generic products. Elite specializes in oral sustained and controlled release drug products with high barriers to entry. Elite owns generic which have been licensed to TAGI Pharma, Epic Pharma, Dr. Reddy’s Laboratories and Glenmark Pharmaceuticals Inc., USA.

Elite currently has eight commercial products currently being sold, six products filed with the FDA, additional approved products pending manufacturing site transfer and the NDA filing for SequestOx™.

Elite’s pipeline products include abuse-deterrent opioids utilizing the Company’s patented proprietary technology and a once-daily opioid. These products include sustained release oral formulations of opioids for the treatment of chronic pain. These formulations are intended to address two major limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential opioid abuse.

Located in Northvale, New Jersey, Elite operates a 55,000 square foot campus under Current Good Manufacturing Practice (“cGMP”) and is a United States Drug Enforcement Agency (“DEA”) registered facility for research, development, manufacturing and packaging of pharmaceutical products.

About Elite's Abuse Deterrent Technology

Elite's abuse deterrent products utilize the Company's proprietary pharmacological abuse deterrent technology. Elite's abuse deterrent technology is a multi-particulate capsule which contains an opioid agonist in addition to naltrexone, an opioid antagonist. Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. When this product is taken as intended, the naltrexone is designed to pass through the body unreleased while the opioid agonist releases over time providing therapeutic pain relief for which it is prescribed. If the multi-particulate beads are crushed, the opioid antagonist, naltrexone, is designed to release. The absorption of the naltrexone is intended to block the euphoria by preferentially binding to same receptors in the brain as the opioid agonist and thereby reducing the incentive for abuse or misuse by recreational drug abusers.
Elite continues to expands the intellectual property for the Company's opioid abuse deterrent technology. Elite now has four US patents, one European patent, and two Canadian patents issued in this area with additional patents pending in the U.S., Canada and Europe.

More information including Elite’s proprietary Abuse Resistant Technology can be found at http://www.elitepharma.com

Products & Pipeline
Elite’s principle product is SequestOx™,  an immediate-release oxycodone with sequestered naltrexone abuse-deterrent opioid product for the management of moderate to severe acute pain. Additional products include bariatric, cardiovascular, antihistamine, skeletal muscle relaxants, antipsychotic, tricyclic antidepressant, along with a number of approved products pending manufacturing site transfer.
Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma, Dr. Reddy's Laboratories and Valeant Pharmaceuticals International. Additional information regarding Elite’s wholly owned products, partnerships, and contract manufacturing can be found at  http://www.elitepharma.com/products

\The list of pipeline products can be found at http://www.elitepharma.com/pipeline-generics
Nasrat Hakim, Chairman, President & Chief Executive Officer
Nasrat Hakim joined Elite in August 2013 as Director, President and Chief Executive Officer. Mr. Hakim has more than 30 years of pharmaceutical and medical industry experience in Quality Assurance, Analytical Research and Development, Technical Services and Regulatory Compliance. He brings with him proven management experience, in-depth knowledge of manufacturing systems, development knowledge in immediate and extended release formulations and extensive regulatory experience of GMP and FDA regulations. Prior to his leading Elite, from 2004 to 2013, Mr. Hakim was employed by Actavis, Watson and Alpharma in various senior management positions. Most recently, Mr. Hakim served as International Vice President of Quality Assurance at Actavis, overseeing 25 sites with more than 3,000 employees under his leadership.  Mr. Hakim also served as Corporate Vice President of Technical Services, Quality and Regulatory Compliance for Actavis U.S., Global Vice President, Quality and Regulatory Compliance for Alpharma, as well as Executive Director of Quality Unit at TheraTech, overseeing manufacturing and research and development. In 2009, Mr. Hakim founded Mikah Pharma, LLC, a virtual, fully functional pharmaceutical company. 

Mr. Hakim’s career started in Medical Laboratory Technology from the Academy of Health and Sciences in the U.S. Army based in San Antonio, TX, followed by Graduate Certification in Regulatory Affairs (RAC) from California State University at Sacramento, Sacramento, CA; Bachelor in Chemistry/Bio-Chemistry and Masters of Science in Chemistry from California State University at Sacramento, Sacramento, CA; and a Masters in Law with Graduate Certification in U.S. Taxation from St. Thomas University, School of Law, Miami, FL.

Investor Relations and Corporate Inquiries

Dianne Will
Vice President of Investor Relations and Corporate Affairs
Telephone: 518-398-6222

Corporate Headquarters
165 Ludlow Avenue
Northvale, New Jersey 07647
Phone: 201-750-2646
Fax: 201-750-2755


Miscellaneous Links:
Elite Pharmaceuticals News
SEC Filings

FDA website

Clinical Trials.Gov

Yahoo Finance
Seeking Alpha

ELTP Daily Chart:

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ELTP News: Proxy Statement (definitive) (def 14a) 10/10/2019 05:06:08 PM
ELTP News: Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) 09/27/2019 04:59:20 PM
ELTP News: Current Report Filing (8-k) 09/12/2019 04:34:12 PM
ELTP News: Current Report Filing (8-k) 08/09/2019 04:53:30 PM
ELTP News: Quarterly Report (10-q) 08/09/2019 04:33:28 PM
#319412  Sticky Note Transcript for August 12, 2019 Conference Call: rrr2003 08/12/19 06:53:18 PM
#315838  Sticky Note In EXACTLY 6 months. aELmTPa 05/10/19 07:27:08 PM
#311210  Sticky Note 2019: Elites 2019 Monster LineUp NASDAQ2020 03/06/19 10:42:08 PM
#303967  Sticky Note Wishfull thinking , elite will need another 100 Dr_Thorfin 11/19/18 08:43:48 AM
#274770  Sticky Note memorable "calls" for elite pharma: dr_lowenstein 10/24/17 04:09:11 PM
#185967  Sticky Note The only topic here is ELTP. IH Dan (Retired) 02/23/16 09:32:46 PM
#322659   Say buy buy to the 3's up from here NASDAQ2020 10/15/19 02:39:57 PM
#322658   Indeed!! a defining moment. namtae 10/15/19 02:28:55 PM
#322657   Agree with Snup, a defining moment. littlerhody 10/15/19 01:53:35 PM
#322656   I think your on to something big! snupoled 10/15/19 01:41:19 PM
#322655   Locked down,loaded! G.t.c./a.o.n. at much higher prices! SnupDawgoled snupoled 10/15/19 01:31:40 PM
#322654   366, SOUNDS LIKE A MM NEEDS HELP steve9465 10/15/19 12:31:34 PM
#322652   Hammer Time! YJ4LIFE 10/15/19 02:12:01 AM
#322651   HammerTime ! NASDAQ2020 10/14/19 10:37:00 PM
#322650   Additional Elite 10 baggers NASDAQ2020 10/14/19 09:50:03 PM
#322649   SunGen ANDA #2 (((((( Elite’s TEN NASDAQ2020 10/14/19 09:44:39 PM
#322648   More and more are being educated about the truth.. https://reason.com/2019/07/ Gman24 10/14/19 07:05:14 PM
#322646   No shares ezchanging hands. Bucket must be empty jbdiver 10/14/19 03:49:31 PM
#322644   It's now fixed. That was fast! aELmTPa 10/14/19 02:29:07 PM
#322643   Just sent the email. aELmTPa 10/14/19 02:23:17 PM
#322642   Sellers have left the building ! NASDAQ2020 10/14/19 02:18:16 PM
#322640   $ELTP lays GOLDEN EGGs YJ4LIFE 10/14/19 01:53:38 PM
#322639   No volatility. Shares are needed. This is a jbdiver 10/14/19 01:25:32 PM
#322638   gonna have to issue more shares.. BjornTrader 10/14/19 10:17:49 AM
#322637   Absolutely agree on that... BjornTrader 10/14/19 10:16:04 AM
#322636   Yes Moose, there are many good things coming YJ4LIFE 10/14/19 09:51:10 AM
#322635   Be Epic lol! Moose45 10/14/19 09:23:16 AM
#322634   The next 15 months is going to Epic!! Moose45 10/14/19 09:21:52 AM
#322633   Okay... got it... DEA quotas for schedule I Jimmy Joe 10/13/19 09:49:09 PM
#322632   Not sure when they award quotas NASDAQ, however, Jimmy Joe 10/13/19 09:37:40 PM
#322631   CNS drugs like Adderall Elite/SunGen given an allotment Jimmy Joe 10/13/19 09:27:55 PM
#322630   Better question; how close is Elite to launching Jimmy Joe 10/13/19 09:22:37 PM
#322629   When does the DEA award quotas ? NASDAQ2020 10/13/19 08:07:13 PM
#322628   Just a measly alcohol dumping test that NASDAQ2020 10/13/19 07:23:28 PM
#322627   The Monster 10 Bagger will be more NASDAQ2020 10/13/19 07:19:43 PM
#322626   Isradipine revenues are rising. NASDAQ2020 10/13/19 07:18:22 PM
#322625   I’m up 171% since the HammerBottom BuyaThon. NASDAQ2020 10/13/19 07:16:08 PM
#322624   It will make Elite a household name ! NASDAQ2020 10/13/19 07:12:34 PM
#322623   2020 Approval. NASDAQ2020 10/13/19 07:11:37 PM
#322622   Adderall XR = 10 bagger..........BY ITSELF. aELmTPa 10/13/19 06:17:39 PM
#322621   EXACTLY 3 weeks from tomorrow: aELmTPa 10/13/19 06:15:49 PM
#322620   And if Elite gets denied Jimmy Joe 10/13/19 05:18:06 PM
#322619   The Bulk of The Monster is Already Approved JustGoDeep 10/13/19 03:51:15 PM
#322618   And if Elite gets denied, it will be jour_trader 10/13/19 02:52:13 PM
#322617   That cant be …. all I heard for IB_ 10/13/19 02:42:52 PM
#322616   Actually ELTP Stock Price is 12% Higher JustGoDeep 10/13/19 02:41:15 PM
#322615   I was wondering the same thing. . is dr_lowenstein 10/13/19 02:37:48 PM
#322614   Revenue for Elites Isradipine to treat Parkinson's Disease IB_ 10/13/19 02:08:52 PM
#322613   LOL the 8 penny share price speaks volumes dr_lowenstein 10/13/19 01:59:15 PM
#322612   Speaking of the December Monster, Got ELTP?? JustGoDeep 10/13/19 01:53:34 PM
#322611   Nah, Next-Year, 2020!! Just Need the December Monster!! JustGoDeep 10/13/19 01:52:15 PM
#322610   decades if ever dr_lowenstein 10/13/19 01:48:43 PM
#322609   And By Then Elite is Doing $200 Million JustGoDeep 10/13/19 01:40:55 PM
#322608   Do The MATH!! Those-Shares Will-Result in Several $100-Million+ JustGoDeep 10/13/19 01:40:10 PM
#322607   misinformation , don't read it carefully JustGoDeep 10/13/19 01:20:58 PM
#322606   misinformation read it carefully dr_lowenstein 10/13/19 01:08:52 PM